310 related articles for article (PubMed ID: 25796272)
1. Innovative therapeutic strategies for recessive dystrophic epidermolysis bullosa.
Larcher F; Del Río M
Actas Dermosifiliogr; 2015 Jun; 106(5):376-82. PubMed ID: 25796272
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
3. Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa.
Dourado Alcorte M; Sogayar MC; Demasi MA
Expert Opin Ther Pat; 2019 May; 29(5):327-337. PubMed ID: 31017019
[TBL] [Abstract][Full Text] [Related]
4. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
[TBL] [Abstract][Full Text] [Related]
5. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
Wenzel D; Bayerl J; Nyström A; Bruckner-Tuderman L; Meixner A; Penninger JM
Sci Transl Med; 2014 Nov; 6(264):264ra165. PubMed ID: 25429058
[TBL] [Abstract][Full Text] [Related]
6. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
Perdoni C; Osborn MJ; Tolar J
Transl Res; 2016 Feb; 168():50-58. PubMed ID: 26073463
[TBL] [Abstract][Full Text] [Related]
7. Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo.
Chamorro C; Almarza D; Duarte B; Llames SG; Murillas R; García M; Cigudosa JC; Espinosa-Hevia L; Escámez MJ; Mencía A; Meana A; García-Escudero R; Moro R; Conti CJ; Del Río M; Larcher F
Exp Dermatol; 2013 Sep; 22(9):601-3. PubMed ID: 23947675
[TBL] [Abstract][Full Text] [Related]
8. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model.
Liao Y; Ivanova L; Sivalenka R; Plumer T; Zhu H; Zhang X; Christiano AM; McGrath JA; Gurney JP; Cairo MS
Stem Cells Transl Med; 2018 Jul; 7(7):530-542. PubMed ID: 29745997
[TBL] [Abstract][Full Text] [Related]
10. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
[TBL] [Abstract][Full Text] [Related]
11. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
Twaroski K; Eide C; Riddle MJ; Xia L; Lees CJ; Chen W; Mathews W; Keene DR; McGrath JA; Tolar J
Br J Dermatol; 2019 Dec; 181(6):1247-1253. PubMed ID: 30924923
[TBL] [Abstract][Full Text] [Related]
12. Correction of Recessive Dystrophic Epidermolysis Bullosa by Transposon-Mediated Integration of COL7A1 in Transplantable Patient-Derived Primary Keratinocytes.
Latella MC; Cocchiarella F; De Rosa L; Turchiano G; Gonçalves MAFV; Larcher F; De Luca M; Recchia A
J Invest Dermatol; 2017 Apr; 137(4):836-844. PubMed ID: 28027893
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
Hong SA; Kim SE; Lee AY; Hwang GH; Kim JH; Iwata H; Kim SC; Bae S; Lee SE
Mol Ther; 2022 Aug; 30(8):2664-2679. PubMed ID: 35690907
[TBL] [Abstract][Full Text] [Related]
14. Type VII Collagen Replacement Therapy in Recessive Dystrophic Epidermolysis Bullosa-How Much, How Often?
South AP; Uitto J
J Invest Dermatol; 2016 Jun; 136(6):1079-1081. PubMed ID: 27212645
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.
Ito K; Sawamura D; Goto M; Nakamura H; Nishie W; Sakai K; Natsuga K; Shinkuma S; Shibaki A; Uitto J; Denton CP; Nakajima O; Akiyama M; Shimizu H
Am J Pathol; 2009 Dec; 175(6):2508-17. PubMed ID: 19893033
[TBL] [Abstract][Full Text] [Related]
16. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa.
Cianfarani F; Zambruno G; Castiglia D; Odorisio T
Am J Pathol; 2017 Jul; 187(7):1445-1453. PubMed ID: 28460207
[TBL] [Abstract][Full Text] [Related]
17. Translating the combination of gene therapy and tissue engineering for treating recessive dystrophic epidermolysis bullosa.
Dakiw Piaceski A; Larouche D; Ghani K; Bisson F; Cortez Ghio S; Larochelle S; Moulin VJ; Caruso M; Germain L
Eur Cell Mater; 2018 Feb; 35():73-86. PubMed ID: 29441510
[TBL] [Abstract][Full Text] [Related]
18. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
[TBL] [Abstract][Full Text] [Related]
19. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
20. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]